The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The design, preclinical study and phase I dose escalation plan of a HER2 targeted immunoliposome (HF-K1) for HER2 low solid tumor treatment.
 
Shanshan Jin
Employment - HighField Biopharmaceuticals
Stock and Other Ownership Interests - HighField Biopharmaceuticals
Honoraria - HighField Biopharmaceuticals
 
Xiaochen Zhang
No Relationships to Disclose
 
Yunlu Jia
No Relationships to Disclose
 
Yongchao Dai
Employment - HighField Biopharmaceuticals
Stock and Other Ownership Interests - HighField Biopharmaceuticals
 
Fengwei Xu
Employment - HighField Biopharmaceuticals
Stock and Other Ownership Interests - HighField Biopharmaceuticals
 
Yongfeng Huang
Employment - HighField Biopharmaceuticals
Honoraria - HighField Biopharmaceuticals
Travel, Accommodations, Expenses - HighField Biopharmaceuticals
 
Xun Wang
Employment - Hangzhou Highfield Biopharmaceuticals Corporation
 
Hailong Wu
Employment - Hangzhou Highfield Biopharmaceuticals Corporation
 
Yu Shao
Employment - Hangzhou HighField Biopharmaceuticals
 
Jinfeng Long
Employment - HighField Biopharmaceuticals
 
Anjie Zheng
Employment - Hangzhou HighField Biopharmaceuticals
Stock and Other Ownership Interests - Hangzhou HighField Biopharmaceuticals
Honoraria - Hangzhou HighField Biopharmaceuticals
Consulting or Advisory Role - Hangzhou HighField Biopharmaceuticals
Patents, Royalties, Other Intellectual Property - All-Trans Retinoic Acid liposome Formulation, And Preparation And Use Therexof
 
Yuhong Xu
Employment - Hangzhou HighField Biopharmaceuticals
Leadership - Hangzhou HighField Biopharmaceuticals
Stock and Other Ownership Interests - Hangzhou HighField Biopharmaceuticals
Patents, Royalties, Other Intellectual Property - hold several patents, but currently no royalty generated